Willingness to Use an Approved COVID-19 Vaccine: Cross-National Evidence on Levels and Individual-Level Predictors
The management of the COVID-19 pandemic critically hinges on the approval of safe and effective vaccines but, equally importantly, on high willingness among lay people to use vaccines when approved. To facilitate vaccination willingness via effective health communication, it is key to understand both levels of skepticism towards an approved COVID-19 vaccine and the demographic, psychological and political sources of this skepticism. To this end, we examine the levels and predictors of willingness to use an approved COVID-19 vaccine in large, representative surveys from eight Western democracies that differ both politically and in terms of the severity of the pandemic: Denmark, France, Germany, Hungary, Sweden, Italy, United Kingdom, and United States (total N = 9,889). The data reveal large variation in vaccination willingness, both across and within countries ranging from 79 % in Denmark to 38 % in Hungary. Thus, most national levels fall below current best estimates for the required threshold for reaching herd immunity. Across national and demographic groups, the analyses demonstrate that a lack of vaccination willingness is associated with low levels of trust in authorities, conspiracy-related beliefs and a lack of concern about COVID-19. These factors also account for cross-national levels in vaccine willingness.